We’re building the
infrastructure to
understand it.
Human milk changes across time, individuals, health and disease.
Registration expresses interest only. It is not enrollment in a study or access to treatment.
What is established about human milk as a biological system, and where Lactome's research questions begin. Established evidence and Lactome hypotheses are labeled separately throughout.
Antibodies, immune cells and cytokines as a changing immunologic system. Evidence
Investigating whether disease-associated biology corresponds with measurable changes in milk. Evidence
Responses of milk composition to maternal and infant infection and immunization. Evidence
The milk microbiome and its interaction with the infant. Evidence
Lipids, oligosaccharides and metabolites across lactation. Evidence
Longitudinal biology of the lactating parent and the infant. Evidence
Proteome, metabolome, transcriptome and microbiome measured together. Evidence
Candidate signals and mechanisms that may warrant translational evaluation. Evidence
Human milk composition varies across lactation, between feeds and between individuals. It delivers nutrients together with a large set of bioactive factors, including immunoglobulins, growth factors, enzymes, oligosaccharides and living cells.1
Established evidence
Secretory IgA is the predominant antibody in human milk and reflects the maternal mucosal immune experience. Specific antibody responses in milk have been documented following maternal infection and immunization.1, 8
Established evidence
Lactoferrin is an abundant milk protein with iron-binding, antimicrobial and immunomodulatory properties described in laboratory and clinical literature.2
Established evidence
Human milk contains leukocytes whose numbers rise during maternal or infant infection, suggesting milk's cellular composition responds to immune challenge.3, 4
Established evidence
A range of cytokines and chemokines is measurable in milk. Their concentrations vary across lactation and with maternal conditions, and their functional roles in the infant are an active area of study.1
Established evidence, mechanisms under study
Human milk oligosaccharides are structurally diverse carbohydrates that are largely indigestible by the infant, shape the gut microbiome and have documented roles in mucosal defense.5
Established evidence
Human milk carries its own bacterial community, and milk-associated bacteria contribute to the establishment of the infant gut microbiome.6
Established evidence
Milk contains extracellular vesicles carrying proteins and RNA. Their recovery depends on sample handling, which is why standardized collection matters for any study of their function.7
Established evidence, function under study
The human milk proteome and metabolome have been characterized in increasing depth, revealing several thousand proteins and a wide range of small molecules that change over lactation.9, 10
Established evidence
Interaction between milk components and infant saliva has been reported to generate reactive compounds that may regulate the oral microbiome of the infant.11 This describes a chemical interaction at feeding; it does not establish that saliva alters milk production.
Reported evidence, limited scope
A diagnosis should never be the end of the questions we ask.
The immune systems of parent and infant interact through milk. The extent to which infant signals influence milk composition, and by which pathways, remains incompletely characterized.3
Partially established, open questions
Rare should never mean overlooked.
Whether biological signals associated with cancer, rare disease or other conditions correspond with reproducible, measurable changes in human milk is not established. This is the central question of the Adaptive Human Milk Project.
Lactome research hypothesis
If adaptive responses in milk can be reproducibly measured, they may reveal candidate biomarkers, mechanisms or molecules that warrant independent validation. No such candidate has been established by Lactome.
Lactome research hypothesis
Citations are provided for orientation and are not exhaustive. Readers should consult the primary literature. Lactome has not published research findings.
Change is one question. Function is another. Lactome investigates both.
The formal institutional research framework: intrinsic biology, adaptive biology, functional significance and the path to validation.
Investigating disease-associated biological signaling and dynamic variation in human milk
Human milk is not a static nutritional substance. It is a dynamic biological system containing immunoglobulins, immune cells, cytokines, proteins, peptides, lipids, human milk oligosaccharides, metabolites, microorganisms, extracellular vesicles, nucleic acids, and other bioactive components whose abundance and composition vary across individuals and over time.
Existing research demonstrates that human milk composition is influenced by numerous maternal and infant factors, including stage of lactation, maternal physiology, infection, immunization, infant health, feeding practices, and characteristics of the maternal-infant biological interface. Interactions between human milk and infant saliva, as well as communication across maternal, mammary, microbial, and infant systems, have generated important questions regarding the extent to which lactation participates in adaptive biological signaling.
Lactome's research program centers on a broader question: Can disease-associated biological signals produce measurable, reproducible changes in human milk?
The Adaptive Human Milk Project is a research framework for investigating both the intrinsic biological activity of human milk and whether health- or disease-associated biological signals correspond with detectable, reproducible changes in its immunologic, cellular, proteomic, metabolomic, microbiologic, transcriptomic, and extracellular-vesicle landscape.
The project does not presume that such responses exist, that they are disease-specific, or that human milk constitutes a treatment for cancer or other diseases. Rather, it proposes that these questions warrant rigorous investigation. If reproducible disease-associated responses are ultimately demonstrated, subsequent research could determine whether those changes reveal previously unidentified biomarkers, biological mechanisms, or molecular candidates worthy of translational investigation.
Human milk represents an unusually complex interface between nutrition, immunity, microbiology, maternal physiology, and infant development. Its composition changes substantially throughout lactation and can differ both between individuals and within the same individual over time.
Beyond macronutrients, human milk contains antibodies and other immunoglobulins; leukocytes and other cells; cytokines and chemokines; lactoferrin and other proteins; peptides; lipids and fatty acids; human milk oligosaccharides; metabolites; microorganisms and microbial products; extracellular vesicles; microRNAs and other nucleic-acid-associated signals; enzymes; and growth factors.
This complexity raises a fundamental scientific question. Human milk may not merely represent a substance that is produced; it may represent a biological system that is continuously changing. Understanding the signals associated with those changes is central to Lactome's proposed research program.
The Adaptive Human Milk Project begins with a deliberately open question: Can disease-associated biological signals correspond with measurable changes in human milk? The project does not assume the answer is yes. Instead, Lactome is developing the research infrastructure required to investigate this question systematically.
Potential measurable domains include immunology, proteomics, metabolomics, extracellular vesicles, microbiology, cellular biology, transcriptomics, and molecular signaling. The objective is not to search for one predetermined molecule. The objective is to characterize the system.
Change is one question. Function is another. Lactome investigates both.
Intrinsic biology asks what biologically meaningful activity is already present in human milk, regardless of whether a measurable adaptive change occurs.
Adaptive biology asks whether defined health-, disease-, immune-, or other biological conditions correspond with reproducible changes in human milk over time.
Functional significance asks whether baseline or altered milk components produce measurable, reproducible effects in appropriate experimental models. Biological importance need not require a large compositional shift: a modest change in a potent antibody, peptide, signaling molecule, metabolite, extracellular-vesicle cargo, immune-cell population, or other bioactive component could be functionally meaningful. Conversely, a large compositional change should not be presumed beneficial without functional evidence.
Accordingly, the program follows a broader research sequence: intrinsic biology → adaptive biology → functional significance → mechanism → validation → potential translation.
The natural maternal-infant relationship provides an important starting point. Human milk composition changes during lactation, while maternal immune activity, infant health, feeding behavior, microbial exposure, and other biological variables can also change.
These observations raise broader unresolved questions: What determines which biological signals influence human milk composition? Could signals associated with disease in another individual correspond with measurable changes in the lactational system?
Lactome does not currently claim that saliva from a patient can 'program' another individual's milk, that exposure to another person's DNA creates biological compatibility, or that a lactating participant can be converted into a therapeutic match for a patient. Those concepts remain speculative. The scientifically meaningful task is to determine whether a phenomenon exists before assigning a mechanism to it.
If a disease-associated effect were observed, a fundamental question would follow: What biological signal is responsible? Possible research candidates might eventually include antigens, microbial components, inflammatory mediators, cytokines, metabolites, extracellular vesicles, proteins or peptides, immune complexes, cell-free nucleic acids, disease-associated molecular patterns, or combinations of signals.
Cancer provides a compelling research context because tumors and the host response to them can generate complex molecular signatures. Rare diseases may provide another important context, while infectious diseases offer models in which immune responses can be measured longitudinally. Accordingly, the Lactome research program is designed to extend beyond any single disease area.
Human milk contains numerous biologically active components, and individual milk-derived molecules and molecular complexes have been investigated experimentally for potential anticancer properties. Such findings do not establish human milk itself as a cancer therapy.
The Adaptive Human Milk Project asks instead whether disease-associated biology corresponds with identifiable changes in milk; whether any such changes are biologically meaningful; and, only after those questions, whether a resulting molecule, pathway, signature, or mechanism warrants translational investigation.
The required progression is: observation, replication, mechanism, validation, and only then potential translation.
A single milk sample provides a snapshot. Repeated samples can reveal change. Longitudinal research can ask what changed, when it changed, how large the change was, how long it persisted, whether the same pattern occurred in other participants, whether it was associated with a defined biological event, and whether the observation can be replicated.
That transition from static sampling to longitudinal biology is fundamental to the Lactome research model.
No single analytical modality is likely to characterize the full biological complexity of human milk. Lactome's research framework integrates, where scientifically appropriate, proteomics, metabolomics, transcriptomics, microbiome analysis, immunologic profiling, cellular characterization, extracellular-vesicle analysis, and carefully structured longitudinal metadata.
The objective would be to identify patterns across biological systems rather than interpret isolated molecular changes without context.
The scientific question requires more than laboratory assays. It requires infrastructure capable of connecting people, specimens, longitudinal information, investigators, and analytical technologies.
Lactome is conceived as both a scientific initiative and a research-enablement platform connecting lactating research participants; patients and families; qualified researchers and institutions; and translational partners capable of investigating validated discoveries.
The platform is being developed to support the identification and investigation of scientifically meaningful cohorts while maintaining appropriate consent, privacy, governance, and institutional oversight.
PARTICIPANTS -> LONGITUDINAL BIOLOGY -> RESEARCH -> MOLECULAR DISCOVERY -> VALIDATION -> POTENTIAL TRANSLATION
Translation is an intended possibility, not a current state.
If disease-associated signals were eventually shown to influence milk composition, investigators could ask whether responses vary according to disease, biological signal, individual participant, timing, route of biological communication, immune history, genetics, microbiome, stage of lactation, or maternal physiology.
Only after establishing such effects would it become scientifically appropriate to investigate whether donor-recipient characteristics have meaningful biological relevance. This possibility must remain a research question, not a premise.
The ultimate value of this research may not necessarily be the direct administration of whole human milk. A reproducible disease-associated molecular response could instead reveal a biomarker, antibody, peptide, protein, lipid complex, extracellular-vesicle component, metabolite, RNA-associated signal, signaling pathway, or another biological mechanism.
Human milk could therefore serve not merely as an object of study, but potentially as a window into adaptive human biology. Whether that possibility is scientifically valid remains to be determined. That uncertainty is precisely why the research is needed.
The scientific ambition of the project requires equally serious ethical governance. Lactome's intended principles include informed consent, participant autonomy, independent ethical review where required, privacy by design, responsible biospecimen governance, protection of pediatric and vulnerable populations, scientific transparency, and no unsupported therapeutic claims.
Research participation must not be represented as treatment.
Lactome does not currently claim that human milk cures cancer; donor milk treats cancer; patient saliva can program another person's milk; disease-associated DNA exposure creates donor compatibility; a lactating participant can currently be biologically matched to a patient; milk produced following exposure to another person's biological material is therapeutic; or any proposed disease-response mechanism has been clinically validated.
These are not established conclusions of the project. Lactome is advancing the infrastructure and collaborations necessary to investigate unanswered biological questions rigorously.
Current and prospective research priorities include establishing longitudinal baselines; studying naturally occurring health events where appropriate; multi-omic characterization; signal discovery; replication; mechanistic investigation using suitable laboratory, computational, ex-vivo, organoid, or other models; and translational evaluation only after sufficient validation.
Lactome is designed to complement—not replace—the work of universities, medical centers, laboratories, and principal investigators. Its value lies in connecting participants willing to contribute with investigators capable of asking rigorous questions, laboratories capable of measuring complex biology, institutions capable of providing ethical and scientific oversight, and translational organizations capable of developing validated discoveries.
Some biological questions are too complex to investigate in isolation. Lactome is actively expanding research and institutional collaborations around this work.
Modern molecular technologies allow researchers to interrogate human milk biology at levels that were previously impossible. Proteomics, metabolomics, sequencing, extracellular-vesicle research, and computational biology can characterize complex biological systems across time.
The opportunity is therefore not simply to ask what human milk contains. It is to ask: How does the system change? What causes those changes? What information do those changes contain? And what might they teach us about human biology?Program Status & CollaborationLactome's research framework and discovery program are actively progressing. Ongoing work is focused on refining the scientific questions, research infrastructure, longitudinal study architecture, and analytical pathways needed to evaluate adaptive variation in human milk. Findings and research development are underway, and Lactome welcomes additional collaboration with qualified investigators, universities, medical centers, laboratories, biotechnology organizations, foundations, and other institutions whose capabilities align with the program's scientific objectives.
Lactome's research framework and discovery program are actively progressing. Current work is focused on advancing the scientific questions, research infrastructure, longitudinal study architecture, functional-assay strategy, and analytical pathways needed to investigate the intrinsic and adaptive biology of human milk. Research development and findings are underway, and Lactome welcomes additional collaboration with qualified investigators, universities, medical centers, laboratories, biotechnology organizations, foundations, and other institutions whose capabilities align with the program's scientific objectives.
Human milk is dynamic biology. Its molecular composition changes across individuals, across lactation, and in association with biological circumstances that science is still working to understand.
The central research program is deliberately broader than a single adaptive hypothesis. Lactome asks what biological activity is already present in human milk, whether defined biological conditions correspond with reproducible changes, and whether baseline or altered components demonstrate functional significance in appropriate experimental models.
If the answer is no, rigorous research should establish that. If the answer is yes, the next questions become more important: Which signals? Which components change? Through what mechanism? How quickly? For how long? Is the response reproducible? Is it disease-associated or disease-specific? Does it reveal anything biologically or clinically meaningful?
Only after those questions have been answered should therapeutic translation be considered. Lactome is advancing the infrastructure, scientific framework, and collaborations needed to make those questions investigable.
Lactome is building a registry of people who may wish to take part in future, ethically governed research. Registering expresses interest only. It does not enroll you in a study, and it never obligates you to take part.
For lactating individuals interested in contributing to future research on human milk as a biological system.
For individuals and families affected by cancer, rare disease, infectious disease or other conditions who want to learn about relevant future research.
Specialized cohorts. Longitudinal data. Biospecimen-enabled research. Multi-omic discovery.
The capabilities below describe what the platform is being built to support. They are not yet an operating service.
Studies are designed and led by qualified investigators. Lactome's role is infrastructure: recruitment, longitudinal data, biospecimen coordination and analytical partnership. Any human-subject research proceeds under the investigator's institutional review and applicable regulation.
Lactome is at an early stage and does not currently report active studies, partnerships or funding.
Universities. Medical centers. Research institutes. Biotechnology. Laboratories. Foundations.
Applicable human-subject research requires appropriate institutional and ethical oversight. Lactome's platform is being designed so that these principles are structural, not optional.
Human milk is one of the most biologically complex substances produced by the human body—and much remains to be understood.
Lactome exists to help investigate what it can teach us.
Lactome is a human biology research and discovery platform built to advance the scientific understanding of human milk as a dynamic biological system. It connects lactating research volunteers, patients and families with universities, medical institutions, biotechnology companies and qualified investigators to enable ethically governed research.
Lactome is at an early stage. Information about people, partners, funding and facilities will be published here as it exists.
Human milk is one system carrying thousands of signals. Studying it well means separating what is present from what changes, and what changes from what matters.
Translation is the intended destination, not a current state. No finding, biomarker or therapeutic efficacy is claimed or established.
Characterized longitudinally and evaluated functionally, across the components that make human milk a biological system rather than a fluid.
Cells.
Antibodies.
Proteins.
Lipids.
Metabolites.
Microorganisms.
Extracellular vesicles.
Molecular signals.
Established science and Lactome hypotheses are labeled separately wherever they appear. Lactome makes no therapeutic claims about human milk and has not published research findings.
We pursue unanswered questions in human biology with rigor, humility and purpose—because deeper understanding can lead to earlier detection, better interventions, less suffering and, ultimately, more time.
Human milk is one of the most biologically complex substances produced by the human body, and it changes—across time, between individuals, and with health and disease. Much of what those changes mean remains to be understood.
Lactome exists to help investigate what it can teach us: as a window into human biology, and as a source of questions that have rarely been asked with the rigor they deserve.
Human-subject research requires appropriate ethical and institutional oversight. Lactome is being designed around that responsibility, so that these principles are structural rather than optional.
Consent.
Autonomy.
Privacy.
Oversight.
Transparency.
Lactome connects lactating volunteers, patients and families with universities, medical institutions, biotechnology companies and qualified investigators, so that important questions do not go uninvestigated for lack of infrastructure.
Volunteers.
Patients and families.
Investigators.
Institutions.
Partners.
For the lives being lived now—and those still to come.
Tell us who you are and how you may wish to take part. This is an expression of interest only; it is not enrollment in a study and does not collect medical information.
Thank you. This registry is frontend-only during the current phase; no data has been transmitted or stored. When the governed backend is live, you will receive a confirmation email.
Tell us how to reach you. Everything else is optional.
We will be in touch. This form is frontend-only during the current phase; delivery is implemented in the next phase.
Choose your portal.
Authentication and portal services are part of the next phase. In the meantime, you can register interest or contact us directly.
Choose the reason for your inquiry so it reaches the right place.
Thank you. This form is frontend-only during the current phase; no message has been transmitted. Routing and delivery are implemented in the next phase.
This notice describes how Lactome handles information collected through this website. It will be expanded as research services launch.
Through the registry and contact forms: name, email, country or region, the kind of participation or inquiry you indicate, optional areas of interest, an organization name if you provide one, and the content of a message. We do not request diagnoses, medical records, genetic information, children's health information, medication history or other protected health information on this website.
To respond to inquiries and, where you have agreed, to inform you about relevant future research opportunities and Lactome initiatives. Registry interest is not enrollment in research; any study would involve its own consent process.
We do not sell personal information. Information is shared with service providers only as needed to operate the website and communications, and with research institutions only in connection with a study you have separately chosen to consider, and only as described in that study's consent.
Lactome applies data minimization and reasonable safeguards proportionate to the information held. Information is retained only as long as needed for the purposes above or as required by law.
This website is not directed to children, and we do not knowingly collect information from anyone under 18.
This notice will be updated as the platform develops. Material changes will be indicated on this page.
By using this website you agree to these terms.
This website provides information about Lactome and allows visitors to express interest in future research or to contact us. It does not provide medical services.
Content on this website is for informational purposes only and is not medical advice, diagnosis or treatment. Nothing here should be understood to claim that human milk treats, prevents or cures any disease. Consult a qualified healthcare professional for medical questions.
Submitting the registry form expresses interest only. Participation in any research study requires a separate informed-consent process under appropriate institutional and ethical oversight.
The Lactome name, mark and website content belong to Lactome unless otherwise indicated. Scientific references belong to their respective authors and publishers.
Do not misuse this website, submit false information, attempt to access non-public systems, or interfere with its operation.
The website is provided as is. To the extent permitted by law, Lactome disclaims warranties and is not liable for damages arising from use of the website.
These terms may be updated as the platform develops. Continued use after changes constitutes acceptance.
